DBV Technologies S.A. ADR buy melinda
Start price
19.11.18
/
50%
€14.52
Target price
22.01.19
€16.42
Performance (%)
-59.69%
End price
22.01.19
€5.85
Summary
This prediction ended on 22.01.19 with a price of €5.85. Massive losses of -59.69% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| DBV Technologies S.A. ADR | - | - | - | - |
| iShares Core DAX® | -2,12 % | -8,18 % | -1,47 % | 54,14 % |
| iShares Nasdaq 100 | -1,13 % | 0,91 % | 19,96 % | 83,32 % |
| iShares Nikkei 225® | -0,66 % | -6,26 % | 27,47 % | 53,61 % |
| iShares S&P 500 | -1,26 % | -1,00 % | 13,63 % | 62,62 % |
Comments by melinda for this prediction
In the thread DBV Technologies S.A. ADR diskutieren
Agenda 11/03 Publication de résultats
Develops non invasive epicutaneous diagnostics systems and immunotherapy for allergy diagnostics
DBV Technologies SA is a clinical-stage biopharmaceutical company, which deals with conducting of research and development of epicutaneous immunotherapy products.
It focuses on developing a novel technology platform called Viaskin, which is an electrostatic patch that offers a convenient, self-administered, non-invasive immunotherapy to patients.
The company has designed two products candidates: Viaskin Peanut and Viaskin Milk.
DBV Technologies was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.
DBV Technologies SA is a clinical-stage biopharmaceutical company, which deals with conducting of research and development of epicutaneous immunotherapy products.
It focuses on developing a novel technology platform called Viaskin, which is an electrostatic patch that offers a convenient, self-administered, non-invasive immunotherapy to patients.
The company has designed two products candidates: Viaskin Peanut and Viaskin Milk.
DBV Technologies was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.
Nombre d'employés : 242 personnes.
(Vom Mitglied beendet)
Stopped prediction by melinda for DBV Technologies S.A. ADR
DBV Technologies S.A. ADR
Start price
Target price
Perf. (%)
€1.26
23.12.22
23.12.22
-
23.12.23
23.12.23
-48.81%
24.12.23
24.12.23
DBV Technologies S.A. ADR
Start price
Target price
Perf. (%)
€8.65
04.06.19
04.06.19
€16.24
04.11.21
04.11.21
-76.99%
04.01.21
04.01.21
DBV Technologies S.A. ADR
Start price
Target price
Perf. (%)
€8.01
04.04.19
04.04.19
€9.02
26.04.19
26.04.19
12.77%
26.04.19
26.04.19
DBV Technologies S.A. ADR
Start price
Target price
Perf. (%)
€20.62
27.04.18
27.04.18
€21.74
14.05.18
14.05.18
5.47%
14.05.18
14.05.18
DBV Technologies S.A. ADR
Start price
Target price
Perf. (%)
€31.90
27.01.17
27.01.17
€33.37
06.03.17
06.03.17
5.86%
06.03.17
06.03.17